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Abstract: We describe the in vivo characterization of microamperometric sensors for the real-time
monitoring of nitric oxide (NO) and oxygen (O2) in the striatum of immunocompromised NOD
SCID mice. The latter strain has been utilized routinely in the establishment of humanized models
of disease e.g., Parkinson’s disease. NOD SCID mice were implanted with highly sensitive and
selective NO and O2 sensors that have been previously characterized both in vitro and in freely
moving rats. Animals were systemically administered compounds that perturbed the amperometric
current and confirmed sensor performance. Furthermore, the stability of the amperometric current
was investigated and 24 h recordings examined. Saline injections caused transient changes in both
currents that were not significant from baseline. L-NAME caused significant decreases in NO (p < 0.05)
and O2 (p < 0.001) currents compared to saline. L-Arginine produced a significant increase (p < 0.001)
in NO current, and chloral hydrate and Diamox (acetazolamide) caused significant increases in
O2 signal (p < 0.01) compared against saline. The stability of both currents were confirmed over
an eight-day period and analysis of 24-h recordings identified diurnal variations in both signals.
These findings confirm the efficacy of the amperometric sensors to perform continuous and reliable
recordings in immunocompromised mice.
Keywords: amperometry; nitric oxide; oxygen; real-time; characterization; NOD SCID;
immunocompromised
1. Introduction
The discovery of severe combined immunodeficiency (SCID) mice was a pivotal advancement
in the development of immunodeficient mice for xenotransplantation [1,2]. The generation of these
so called “humanized mice” that are reconstructed with human cells can facilitate analysis of the
underlying mechanisms of human disease pathogenesis [1]. Heretofore a myriad of humanized mouse
models exists using these mice specifically, due to their unparalleled ability to facilitate xenografts
implantation and permit anatomical integration of cells and tissue. In particular models for cancer [3,4],
HIV [5,6] and liver disease [7,8] have been established that facilitate focused research of human disease
which was previously impossible in immunocompetent animals [1].
More recently, colleagues have generated and characterized a humanized mouse model of
Parkinson’s disease (PD) through xenotransplantation of induced pluripotent stem cell (iPSC) derived
dopaminergic neurons into NOD SCID mouse striatum [9–11]. These PD patient-derived iPSC’s are
differentiated into dopaminergic neurons and transplanted into the striatum of NOD SCID mice to
facilitate anatomical integration over several months. To date, there has been limited translation from
existing animal models of PD to clinical neuroprotection in human populations. A large number of
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potentially neuroprotective compounds from a broad range of pharmacological groups have been
identified in rodent and primate models, however, none have proven neuroprotective during clinical
testing [12]. The general consensus is that this disparity is mainly due to the aetiopathogenic diversity
of PD and humanised models can potentially bridge the gap between standard pre-clinical animal
models of PD and clinical translation.
Neurochemical analysis has incorporated a wide range of techniques to date, in an attempt to
elucidate the function and pathways of the various neurotransmitter systems in the intact mammalian
brain. This includes the non-invasive techniques; positron emission topography (PET) and functional
magnetic resonance imaging (fMRI), which monitor shifts in brain function [13] and neuronal
activity [14] but suffer from poor temporal resolution. In comparison, invasive techniques, such
as microdialysis and in vivo amperometry provide improved temporal resolution with the latter
facilitating the real time recording of neurochemical dynamics in brain extracellular fluid (ECF) using
highly sensitive and selective microelectrodes (sensors). This is achieved through the application
of a suitable potential profile to the implanted sensor and the trend in a specific neurochemical is
measured continuously and with sub second time resolution. Selectivity is critical due to the large
number of possible interfering species present at relatively high concentrations, (e.g., ascorbic acid
(AA), uric acid (UA), and neurotransmitters including dopamine (DA) and serotonin (5-HT)) in the
mammalian brain. We have extensive experience in the development and characterization of in vivo
sensors and heretofore long term amperometric recordings have been performed by most groups
exclusively in freely moving rats [15–20]. However, the option to undertake measurements in freely
moving immunocompromised mice offers access to novel humanized animal models of disease.
Therefore, the principle objective of the work described within was to characterize existing
amperometric sensors for the continuous measurement of nitric oxide (NO) and oxygen (O2) and
demonstrate their functionality in the striatum of freely moving NOD SCID mice. Moreover, the ability
of this mice strain to facilitate chronic amperometric recordings was investigated thoroughly as a
prerequisite for eventual deployment in a humanised mouse model of PD. This humanised mouse
model will eventually facilitate unprecedented access to perform amperometric recordings within the
microenvironment of transplanted PD human cells. Characterization of the respective sensor signals
was achieved by validating the response of the sensor to the analyte of interest and exhibiting a stable
signal over a number of days to facilitate reliable, continuous long term recordings. To the best of our
knowledge, this article is the first to detail the continuous real time recording of NO and O2 levels in
the brain of NOD SCID mice using amperometric sensors.
2. Materials and Methods
2.1. Chemicals and Solutions
Nafion® (5 wt % solution in a mixture of lower aliphatic alcohols and H2O), graphite powder,
and silicon oil, used in the manufacture of sensors were purchased from Sigma Aldrich Chemical
Co. (Dublin, Ireland). The reagents used in phosphate buffered saline (PBS); sodium chloride (NaCl,
0.15 M), sodium hydroxide (NaOH, 0.04 M) and sodium hydrogen phosphate (NaH2PO4, 0.04 M) were
purchased from Sigma Aldrich Chemical Co. For carbon monoxide (CO) and hydrogen sulphide (H2S)
interference studies, CO gas (research grade) was sourced from BOC (Bluebell, Dublin, Ireland) and
sodium sulphide nonahydrate was sourced from Sigma Aldrich Chemical Co.
2.2. In Vivo Compounds
All compounds used throughout the experiments were purchased from Sigma Chemical Co.
(Dublin, Ireland) except for chloral hydrate which was obtained from BDH Laboratory Supplies (Poole,
UK). In all cases, systemic administration of L-arginine (200 mg·kg−1), L-NG-Nitroarginine methyl ester
hydrochloride (L-NAME, 30 mg·kg−1), chloral hydrate (350 mg·kg−1) and acetazolamide (Diamox,
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50 mg·kg−1) occurred by intraperitoneal (i.p.) injection. All solutions were prepared using 0.9% saline
solution and administered in a volume of 1 mL·kg−1.
2.3. Amperometric Sensor Recordings
Amperometric NO recordings were performed using previously characterized Nafion®-coated
platinum (Pt) disk electrodes manufactured from Teflon®-insulated platinum/iridium (Pt/Ir 90%/10%)
wire (127 µm bare diameter 5T, Science Products GmbH, Hofheim, Germany). The electrodes were
modified as previously described [19,21,22]. NO pre-calibrations were performed in a standard
three-electrode glass electrochemical cell containing PBS electrolyte. A saturated calomel electrode
(SCE) acted as the reference electrode and a Pt rod utilised as the auxiliary electrode. Increasing
concentrations of NO, manufactured in house [21], were injected in to the cell and the electrolyte
solution was agitated using a magnetic stirrer (see Supplementary Material Figure S1). The current
was then measured under quiescent conditions with an N2 atmosphere maintained over the solution to
avoid quenching by ambient O2. Reported concentration changes are based on in vitro pre-calibration
curves (average slope/sensitivity of 1040 ± 50 pA·µM−1, n = 23) recorded for all NO sensors (see
Figure S1). NO sensor selectivity has been published previously [22] and performance was confirmed
by determining the current responses to a myriad of electroactive interferents present in the brain
extracellular fluid at concentrations representative of their physiological levels. The NO sensors
demonstrated negligible responses (<1%) from most of the interfering species including ascorbic acid,
serotonin, DOPAC, dopamine, L-gluthathione, hydrogen peroxide, 5-HIAA, homovanillic acid, nitrite
and uric acid. Further selectivity studies were undertaken against more recent identified interferents
including the electroactive gasotransmitters CO and H2S. Concentrations representative of their
physiological levels were chosen [23,24]. A comparable selectivity over H2S (<1%, 1.6 ± 0.1 pA·µM−1,
n = 4) and a slightly higher contribution from CO (ca. 2%, 22.7 ± 0.1 pA·µM−1, n = 4) was observed
(see Figure S2). Previously published data [19,22] has reported on the stability and sensocompatability
of the NO sensor. Membrane biofouling is a process that starts immediately upon contact of the sensor
with the brain tissue. Previously we have shown in vitro that initial exposure of the sensor to proteins
and lipids results in a significant decrease in sensitivity over the initial 24 h, however, an additional
48-h exposure had no further effect [22]. This resulted in a decrease of ca. 38% which is in line with
other reports where a decrease of between 20% and 50% have been observed following initial exposure
of sensors to brain tissue [25,26]. Furthermore, in vivo investigations support our assumption by
confirming no significant difference in mean baseline current over a successive eight-day period in
the striatum of freely moving rats [19]. The surface integrity of the implanted NO sensor has been
validated further by systemic administration of electroactive interferents which caused no change in
amperometric current in freely moving rats [19,20]. Prior to implantation of NO sensors, selectivity
was confirmed by calibrating against ascorbic acid (AA) at a supraphysiological concentration which
confirms membrane integrity (see Figure S3).
Amperometric O2 recordings were performed using carbon paste electrodes (CPEs). CPEs were
manufactured from Teflon®-insulated silver (Ag) wire (200 µm bare diameter 8T, Advent Research
Materials; Oxford, UK) using protocols previously characterized by others [18,27]. O2 pre-calibrations
were performed in a standard three-electrode glass electrochemical cell containing PBS electrolyte.
A saturated calomel electrode (SCE) acted as the reference electrode and a Pt rod utilised as the
auxiliary electrode. As reported previously by others, the PBS was saturated with either N2 gas (0 µM
O2, BOC Ireland, Dublin, Ireland), atmospheric air (240 µM O2, RENA air-pump) or O2 gas (1200 µM
O2, BOC Ireland) for 20 min and the appropriate gaseous atmosphere was maintained for 15 min over
the cell solution during quiescent recordings (see Figure S4). CPEs demonstrate excellent stability
by retaining their structural integrity following exposure to in vivo fouling conditions. Reported
concentration changes are based on in vitro pre-calibration curves (average slope/sensitivity of
−1.69± 0.04 nA·µM−1, n = 17) (see Figure S4). The selectivity of CPEs has been reported previously by
Bolger et al. [27] with negligible responses observed for the myriad of interferents investigated. Briefly,
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<1% contribution to the O2 signal was observed for ascorbic acid, homovanillic acid, L-gluthathione,
L-cysteine, uric acid, serotonin, L-trypthophan, D-hydroascorbic acid, L-tyrosine, dopamine, DOPAC
and 5HIAA. The absence of O2 signal interference was expected since the large faradaic currents
generated as a result of O2 detection and the reductive nature of the applied potential mitigate against
any potential sources of interference. Furthermore, it is widely documented that CPEs are extremely
stable, even after a couple of weeks of continuous recording in the brain [28,29] due to the presence of
the pasting oil in the CPEs affording them their resistance to poisoning in a lipid-protein matrix.
2.4. In Vivo Implantation and Surgery Protocol
NOD SCID mice (25–40 g) were housed in individually ventilated cages, with a maximum of
five per cage in a temperature (17–23 ◦C), humidity and light controlled (12 h light, 12 h dark cycle)
environment. Food and water were available ad libitum. Amperometric sensors were implanted
following a previously described procedure [19,20] into the right or left striatum (n = 1/animal).
Coordinates with the skull levelled between bregma and lambda were as follows; NO and O2 sensors:
A/P + 0.5, M/L ± 1.5 from bregma and D/V − 4.0 from skull. Reference and auxiliary electrodes
(8T Ag wires, 200 µm bare diameter) were placed in the cortex and soldered to a stainless steel
support screw respectively. The electrodes were fixed to the skull with support screws and dental
acrylate (Agnthos, Lidingö, Sweden). The mice were anesthetized with isoflurane anaesthesia (Abbott
Laboratories, Dublin, Ireland), placed in a Stoelting stereotaxic frame (Stoeling Co., Wood Dale, IL,
USA) and kept on a thermal pad with rectal probe (Stoeling Co.) to prevent hypothermia. A 10 mg·kg−1
s.c injection of the NSAID analgesic, Carprofen® is administered at least 10 min prior to the incision in
the scalp. Subsequently, Lidocaine analgesic (5 mg·kg−1) is applied topically to the incision site for
local pain relief. Once surgery is complete, the animal is allowed to recover for a minimum of 24 h in its
recording cage where it remains for the duration of the experiment. All experimental procedures were
performed under license AE19124/P010 in accordance with the European Communities Regulations
2002 (Irish Statutory Instrument 165/2013).
2.5. Animal Experimental Conditions
All amperometric recordings in freely moving mice were carried out with the animal in an open
top recording cage. Implanted amperometric electrodes were connected to a potentiostat through
a six-pin Teflon socket and a bespoke screened four core cable manufactured in house which was
mounted through a swivel slip ring (CPC Farnell, Preston, UK) above the subject’s head. This cable and
swivel arrangement allowed free movement of the subject and permitted continuous amperometric
recordings for up to five days at a time with an intermittent two-day disconnection period. The desired
potentials: +900 mV vs. Ag wire, and −650 mV vs. Ag wire were applied to the NO and O2 sensors
respectively and the currents were allowed to stabilise for a minimum of 24 h prior to any perturbation
being performed.
2.6. Instrumentation, Software and Data Analysis
The amperometric current was detected using a potentiostat (Quadstat, eDAQ Ltd., Sydney,
Australia) and converted using an A/D converter (eCorder, eDAQ Ltd.). The digital signal was then
recorded using eChart software (v5.5, eDAQ Ltd.) running on a Dell Laptop. Signal processing
was performed on collected data to further improve signal to noise ratios using the eChart software.
All data analysis was performed using GraphPad Prism v5 (GraphPad Software Inc., San Diego, CA,
USA). For characterization and stability investigations, all figures presented are averaged across all
animals and had baseline currents normalised to 100% illustrating the overall change in current as a %
of the pre-perturbation baseline level. This removes both inter electrode and inter animal variability
by ensuring that the presented current changes are representative of the data from all the animals used
in each study. For 24-h investigations, all figures presented had currents converted to concentration
using in vitro calibration data and a 30 min baseline was averaged for each sensor which was then
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set as zero. The significance of differences observed was estimated using the Student’s t-test for
paired/unpaired observations (where appropriate) and one-way ANOVAs with Bonferroni post hoc
test (where appropriate). Two-tailed levels of significance were used with p < 0.05 considered to be
significant. All data is presented as mean ± standard error (SEM), with n = number of animals except
for 24 h recordings where n = number of days or nights/number of animals. One sensor implanted
per animal.
3. Results and Discussion
3.1. Effect of Control Saline Injections on NO and O2 Currents in the Striatum of Freely Moving NOD
SCID Mice
All compounds were prepared using 0.9% saline solution and administered by intraperitoneal
injection in a volume of 1 mL·kg−1. Therefore, it was imperative to characterize the sensor response to
control saline injections. The averaged raw data % current responses following saline administration
(n = 5) are detailed in Figure 1. Briefly, the maximum current change for NO (−4 ± 3 pA) and O2
(−2 ± 3 nA) sensors were not significantly different from pre-injection baseline levels (490 ± 79 pA
(p = 0.30) and 199 ± 14 nA (p = 0.64)) respectively. Maximum responses were recorded for NO after
(1.0 ± 0.1 min) and O2 (3.0 ± 1.7 min) that corresponded to percentage changes of (NO, −0.4% ± 0.8%
and O2, −0.6% ± 1.3%) and concentration changes of (NO, 4 ± 3 nM and O2, 1 ± 2 µM) based on
pre-calibration data. The currents had returned back to a new recorded level for NO (488 ± 80 pA,
p = 0.45) and O2 (200 ± 14 nA, p = 0.49) after 3.0 ± 0.9 min and 10.8 ± 7.1 min respectively.
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These transient responses are in line with previous findings from data obtained from brain
extracellular fluid in freely moving rats. Short lived changes from baseline levels were reported for
both NO [19,20] and O2 [18] sensors following saline injection with no long lasting effect recorded in
either signal.
3.2. Effect of Systemic Administration of the NOS Inhibitor L-NAME on NO and O2 Currents in the Striatum
of Freely Moving NOD SCID Mice
L-NAME is a non-selective nitric oxide synthase (NOS) inhibitor which exerts its function through
direct competition with the pre cursor L-arginine for its binding site on the NOS enzyme [30]. NOS
inhibition has been shown to induce constriction of cerebral vessels and decrease tissue blood flow in
the brain providing evidence that basal NO is involved in the maintenance of cerebral perfusion [31–33].
The averaged raw data % current traces following the systemic administration of 30 mg·kg−1 L-NAME
(n = 5) are illustrated in Figure 2. The maximum current change for NO (−31 ± 8 pA) and O2
(−44 ± 4 nA) sensors were significantly different from pre-injection baseline levels (436 ± 86 pA
(p < 0.01) and 199 ± 12 nA (p < 0.001) respectively. Furthermore, significant changes against saline
controls were observed for both NO (p < 0.05, see Figure 2A inset) and O2 (p < 0.001, see Figure 2B inset).
Maximum responses were recorded for NO (41 ± 18 min) and O2 (28 ± 6 min) that corresponded
to percentage changes of (NO, −6% ± 1% and O2, −19% ± 3%) and concentration changes of (NO,
30 ± 8 nM and O2, 26 ± 2 µM) based on pre-calibration data. The currents had reached a new recorded
level for NO (430 ± 84 pA, p = 0.17) and O2 (181 ± 12 nA, p < 0.01) after 180 min. These results
corroborate previously reported findings whereby L-NAME has been utilised in the characterization
of the NO sensor in wistar rats to great effect [19,20]. Heretofore, its application in O2 sensor
characterization studies has not been reported. Notwithstanding this, it is an ideal compound for
characterization studies since the tissue O2 current measured by the amperometric sensor is determined
by the balance between vasculature supply and cellular utilisation. By this rationale, the decrease
observed in Figure 2B can be attributed to a decrease in O2 supply arising from vasoconstriction
and utilization remaining constant. A net decrease in O2 current is thus recorded. Taken collectively,
a decrease in both NO and O2 current over a 180 min support a correlatory response and thus provide
direct real time evidence of NO’s involvement in cerebral circulation. However, a slight discrepancy
in maximum response times is observed which could be explained by the non-selective nature of
L-NAME. Specifically, inhibition of endothelial NOS (eNOS), which is localised to the smooth muscle
of blood vessels, would exert its effect directly on blood flow by inducing vasoconstriction which
would reduce the levels of O2 available in the brain extracellular fluid. Moreover, it is a generally
accepted phenomenon that neuronal NOS (nNOS) is the most abundantly present isoform in the brain
that is tightly associated with NMDA receptor function on post synaptic membranes [34].
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Considering this, it is therefore plausible that the majority of NO measured at the sensor source
is of neuronal form which would explain the temporal disparity observed between both signals in
Figure 2.
3.3. Effect of Systemic Administration of the NO Precursor L-arginine on NO Currents in the Striatum of Freely
Moving NOD SCID Mice
NO pr duction proceeds through he amino acid L-arginine, which in the presence of various
co-factors and molecular O2, binds to its site on the NOS enzyme to produce NO and L-citrulline:
L-citrulline+ 2NADPH +O2 → L-citrulline+ NO+ 2NADP+
The nitrogen of NO is derived from the guanidine nitrogen atoms of L-arginine and the oxygen
from molecular O2 with the production of a stoichiometric equivalent concentration of the co-product
L-citrulline [35]. L-arginine has been used previously to characterize the NO sensors in freely moving
rats with significant differences observed against baseline and control saline administrations [20,22].
Furthermore, local perfusion of the precursor using retro-microdialysis initiated significant increases
in NO current [19]. Th averaged raw data trace following the syste ic adminis ration of 200 mg·kg−1
L-arginin is illustrated in Fi ure 3. A significant in rease (p < 0.001) in current was observed
(23 ± 4 pA, n = 5) in comparison to pre-injection baseline levels of 545 ± 99 pA an against
saline controls (p < 0.001, see Figure 3 inset). This current change reached a maximum level after
48 ± 9 min and corresponded to a percentage change of 5% ± 1% and concentration change of
22 ± 4 nM based on pre-calibration data. A new baseline current of 545 ± 98 pA was reached after
128 ± 18 min and was not significantly different (p = 0.95) when compared against initial pre-injection
levels. These results confirm that amperometric currents increase following systemic administration
of the pre-cursor in NO synthesis, L-arginine, supporting the efficacy of the sensor in determining
increasing NO concentrations.
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A new baseline current of 195 ± 13 nA was reached after 97 ± 9 min and was not significantly
different (p = 0.33) when compared against initial pre-injection levels. These results strongly corroborate
previously reported findings from O2 sensors implanted in wistar rats [18] and confirmed the efficacy of
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3.5. Effect of Systemic Administration of the Carbonic Anhydrase Inhibitor Diamox on O2 Currents in the
Striatum of Freely Moving NOD SCID Mice
The carbonic anhydrase inhibitor acetazolamide (Diamox) has been shown to increase cerebral
blood flow (CBF) and O2 levels in both humans and animal models [36,37]. Measurement of the CBF or
blood velocity response to Diamox is commonly used to assess the vasodilatory capacity of the cerebral
circulation and moreover, it has been routinely utilised in the characterization of the amperometric O2
sensor in Wistar rats [18]. The averaged raw data % current response following 50 mg·kg−1 Diamox
administration (n = 5) is detailed in Figure 4B. Briefly, the maximum current change (19 ± 4 nA) was
significantly different from pre-injection baseline levels (221 ± 23 nA (p < 0.05) and against saline
controls (p < 0.01, see Figure 4B inset). A maximum response was recorded after 15 ± 3 min that
corresponded to a percentage change of 8% ± 2% and a concentration change of 11 ± 2 µM based on
precalibration data. The currents had returned back to a new recorded level (220± 23 nA, p = 0.80) after
97 ± 27 min. These results strongly corroborate previously reported findings from sensors implanted
in wistar rats [18] and confirm the efficacy of the O2 sensor at measuring concentration changes in the
striatum of NOD SCID mice.
3.6. Stability of the NO and O2 Currents in the Striatum of Freely Moving NOD SCID Mice
The mammalian brain presents a complex chemical environment that includes electrode poisons
such as lipids and proteins and a tissue matrix that both restricts ass transport to the electrode
surface and reacts physiologically to the presence of t e se sor. It is i perative that the sensor
demonstrates efficient stabilit f c ntinuous long term recordings. The potential benefits of
pre-treating micro lectrodes with l pids [29,38] and proteins [39] has b en investigated by research
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groups to permit more accurate pre-calibration techniques by mitigating this sensitivity decrease
observed upon implantation. These studies have established that exposing the electrodes to fouling
agents in vitro may serve as a good model of the behaviour of implanted sensors in brain tissue.
Previous in vivo investigations using the described NO and O2 sensors in the brain ECF of freely
moving rats, confirm no significant difference in mean baseline NO current over a successive eight
day period [19] or in the mean baseline O2 current over a number of weeks [27]. This follows an
early reduction in baseline stability which has been corroborated by other groups where a decrease in
sensitivity has been observed following initial exposure of sensors to brain tissue [25,26]. A similar
phenomenon was observed in the striatum of NOD SCID mice. Figure 5 illustrates the average %
baseline current recorded from the mice over an eight-day period which supports previous evidence
recorded from Wistar rats. Day 1 baselines were normalised to 100% and all subsequent baselines are
normalised to a percentage of the baseline recorded on Day 1.
Sensors 2017, 17, 419 10 of 15 
 
groups to permit more accurate pre-calibration techniques by mitigating this sensitivity decrease 
observed upon implantation. These studies have established that exposing the electrodes to fouling 
agents in vitro may serve as a good model of the behaviour of implanted sensors in brain tissue. 
Previous in vivo investigations using the described NO and O2 sensors in the brain ECF of freely 
moving rats, confirm no significant difference in mean baseline NO current over a successive eight 
day period [19] or in the mean baseline O2 current over a number of weeks [27]. This follows an early 
reduction in baseline stability which has been corroborated by other groups where a decrease in 
sensitivity has been observed following initial exposure of sensors to brain tissue [25,26]. A similar 
phenomenon was observed in the striatum of NOD SCID mice. Figure 5 illustrates the average % 
baseline current recorded from the mice over an eight-day period which supports previous evidence 
recorded from Wistar rats. Day 1 baselines were normalised to 100% and all subsequent baselines are 
normalised to a percentage of the baseline recorded on Day 1. 
 
Figure 5. Average % baseline currents for (A) NO sensors (n = 6) and (B) O2 sensors (n = 5) implanted 
in the striatum of NOD SCID mice. 
Initially there was a drop in current observed on Day 2 which has been reported by other groups, 
however, no significant variation in NO (p = 0.62, one-way ANOVA; six animals) and O2 (p = 0.74, 
Figure 5. Average baseline c rrents for ( ) sensors (n 6) an ( ) 2 sensors (n = 5) implanted
in the striatu of S I ice.
Sensors 2017, 17, 419 11 of 15
Initially there was a drop in current observed on Day 2 which has been reported by other groups,
however, no significant variation in NO (p = 0.62, one-way ANOVA; six animals) and O2 (p = 0.74,
one-way ANOVA; five animals) signal was reported over subsequent days which demonstrates the
stability of both amprometric sensors over an eight-day recording period.
3.7. 24 Hours Recording of NO and O2 Concentration Dynamics in the Striatum of Freely Moving NOD
SCID Mice
Continuous 24 h amperometric recordings were examined to identify approximate concentration
changes over extended periods of inactivity (light cycle) and increased locomotor activity (night cycle)
based on pre-calibration data. It is apparent from Figure 6 that increasing concentrations of NO
(n = 12/5) and O2 (n = 16/5) coincide with increasing locomotor and behavioural activity routinely
associated with nocturnal species.
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In contrast, light phase concentrations fluctuated around basal levels during extended periods of
hypolocomotion and inactivity (NO: n = 11/5 and O2: n = 10/5). These findings support a diurnal
modulation of both gaseous molecules in NOD SCID mouse striatum that corresponds to changes
in behavioural and general locomotor activity. The obvious similarities observed in NO and O2
trends during nocturnal periods (see Figure S5) may represent increases in cerebral haemodynamics
associated with elevated neural activity during the dark phase. Previously, Endo et al. reported a
comparable diurnal variation in local CBFin awake rat hippocampus, over a 24 h period using the
hydrogen clearance technique [40]. They proposed that this increase is directly related to increased
neuronal function. The close relationship between neuronal activity and local regulation of CBF
through intricate vasoactive mechanisms has long been recognised [41]. Nevertheless, the mechanisms
that modulate the coupling between CBF and neuronal activity in the mammalian brain remain
unresolved. Traditionally, it was accepted that active neurons generate a metabolic signal in response
to increasing O2 or glucose demand, triggering an increase in CBF. In recent times a theory has evolved
suggesting that neurotransmitter mediated signalling, particularly by glutamate has a critical function
in regulating CBF through the initiation of a multifaceted vasodilatory pathway [42], including NO.
The temporal effects of NO and O2 currents illustrated in Figure 6 and Figure S5 support the latter
mechanism. Increasing NO concentrations precede O2 increases during periods of neuronal activation
that is closely associated with nocturnal activity to compensate for cerebral metabolic demands.
Separate work undertaken by Kostin and colleagues using the amperometric NO sensor in freely
moving rats, corroborate this prolonged increase measured during the dark phase [43]. However, given
the hypothesised role of NO in the regulation of sleep, their approach demonstrated that NO levels in
the perifornical-lateral hypothalmic area exhibit sleep-wake as well as diurnal modulation with highest
levels measured during the dark phase. They postulate that NO concentrations in this brain region are
increased during the dark phase to inhibit neurons and aid in the promotion of sleep. Further work is
necessary to determine the exact mechanisms responsible, however, the diurnal variations observed
during these 24-h recordings using the amperometric sensors are a clear indication of their capability
to measure long term neurochemical dynamics in awake, freely moving subjects.
4. Conclusions
The principle objective of the work described within was to demonstrate the functionality of
previously characterized amperometric sensors for the continuous real time monitoring of NO and
O2 in the striatum of freely moving NOD SCID mice. The latter animal strain is utilsed routinely for
humanized models of disease and the reported findings within are critical for the future deployment
of these amperometric sensors in humanized mouse models of disease. Table 1 summarizes the
characterization data obtained for both NO and O2 sensors from the brain extracellular fluid of the
immune-compromised mice.
Table 1. Summary of in vivo characterization data for NO and O2 sensors implanted in the striatum of
freely moving NOD SCID mice (n = 5). * denotes level of significance.
Administration ∆ I ∆ Conc vs. Baseline vs. Saline
Saline (NO) −4 ± 3 pA 4 ± 3 nM p = 0.30 -
Saline (O2) −2 ± 3 nA 1 ± 2 µM p = 0.64 -
L-NAME (NO) −31 ± 8 pA 30 ± 8 nM ** p < 0.01 * p < 0.05
L-NAME (O2) −44 ± 4 nA 26 ± 2 µM *** p < 0.001 *** p < 0.001
L-arginine (NO) 23 ± 4 pA 22 ± 4 nM *** p < 0.001 *** p < 0.001
Chloral hydrate (O2) 87 ± 22 nA 51 ± 13 µM * p < 0.05 ** p < 0.01
Diamox (O2) 19 ± 4 nA 11 ± 2 µM * p < 0.05 ** p < 0.01
Briefly, transient current changes were observed for both sensors following control saline injections.
Significant differences in NO current were recorded for both L-NAME and L-arginine relative to
Sensors 2017, 17, 419 13 of 15
baseline and saline injections. Similarly, significant differences in O2 current were recorded for
L-NAME, chloral hydrate and Diamox with respect to baseline and saline administrations. The stability
of the NO and O2 current was confirmed over an eight-day period and analysis of 24-h signal recordings
identified diurnal variations for both sensors. The latter confirms the efficacy of the amperometric
technique at measuring long-term neurochemical variations in immuno-compromised mice.
Supplementary Materials: The following are available online at http://www.mdpi.com/1424-8220/17/2/419/s1.
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